Service d'Exploration et pathologie du sommeil, Hôpital Femme Mère Enfant
Bron, 69677, France
NCT Number: NCT02799849
A significant weight gain and obesity are observed for most patients with narcolepsy, mainly at the beginning of the disease and narcolepsy in young children. There is no specific study on the population and the consequences of overweight in the lives of these long-term patients. Narcoleptic patients gain weight significantly at the onset of their illness. It is also known that weight gain is not related to the treatment of narcolepsy. The etiology of obesity in narcoleptic patients is not established. Several assumptions were made (physical activity, leptin diet, metabolism). The reason and the pathophysiology of overweight and obesity in this population therefore remain unclear.
In this study, potential change in the total metabolism (24h) for narcoleptic children that could explain their tendency to obesity will be assessed ?
Looking for future studies?
Notify Me6 year–18 year
All sexes
Interventional
Not applicable
Bron, 69677, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
NARCOLEPTIC PATIENTS
HYPERSOMNIC PATIENTS
Exclusion criteria
NARCOLEPTIC PATIENTS
HYPERSOMNIC PATIENTS
Time frame: 15 days
Total energy expenditure in kilocalories per minute, including basal metabolic rate (MET) metabolism related to the activity (EEA), and physical activity (PA) measured by accelerometer (Actical) evaluated at home (15 days including scholar and non-scholar days).
Time frame: 18 days
Total energy expenditure in kilocalories per minute, including basal metabolic rate (MET) metabolism related to the activity (EEA), and physical activity (PA) measured by accelerometer (Actical) evaluated at hospital over 24 hours.
Time frame: 18 days
The basal metabolism (MET) measured by accelerometer (Actical, BodyMedia SW Actiheart) will be compared to the values of energy expenditure (kcal) measured by indirect calorimetry fasting.
Time frame: 18 days
Energy expenditure (kcal) measured by indirect calorimetry after lunch (with counting calories ingested).
Time frame: 18 days
Estimated from IBI (Interbeat Interval) measured by Actiheart.
Time frame: 18 days
Caloric intake evaluation (kcal per day) during hospitalization (food intake recording) and at home during three days ( two days during the week and one day during the week-end) evaluated by questionnary.
Time frame: 18 days
Time frame: 18 days
bodyweight (kg)
Time frame: 18 days
Body height (cm)
Time frame: 18 days
Waist and hips circumference (cm)
Time frame: 18 days
Measurement of neck (cm)
Time frame: 18 days
Measurement of BMI Z-score
Time frame: 18 days
appetite evaluation by visual analog scale before each meal
Time frame: 18 days
hunger evaluation by visual analog scale before each meal
Time frame: 18 days
Time frame: 18 days
Time frame: 18 days
Time frame: 18 days
Time frame: 18 days
Time frame: 18 days
Time frame: 18 days
Time frame: 18 days
Time frame: 18 days
Hospices Civils de Lyon
Other
Is There a Change in the Total Metabolism Over 24 Hours for Narcoleptic Children That Could Explain Their Tendency to Obesity?
Acronym: Narcolepsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05615584
Cataplexy, Disorders of Excessive Somnolence
Montpellier, France
View Trial DetailsNCT05709873
Disorders of Excessive Somnolence, Dyssomnias
Chicago, Illinois, United States
View Trial DetailsNCT03881852
Cataplexy, Cataplexy Narcolepsy
Birmingham, Alabama, United States
View Trial DetailsNCT06586138
Anxiety Disorders, Apnea
Lyon, France
View Trial Details